Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:143-149
Published online before print October 27, 2005, doi: 10.1161/01.ATV.0000193510.19000.10
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/1/143    most recent
01.ATV.0000193510.19000.10v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lau, P. P.
Right arrow Articles by Chan, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lau, P. P.
Right arrow Articles by Chan, L.
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Functional genomics
Right arrow Gene regulation
Right arrow Growth factors/cytokines
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:143.)
© 2006 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Nicotine Induces Proinflammatory Responses in Macrophages and the Aorta Leading to Acceleration of Atherosclerosis in Low-Density Lipoprotein Receptor–/– Mice

Paul P. Lau; Lan Li; Aksam J. Merched; Alan L. Zhang; Kerry W.S. Ko; Lawrence Chan

From the Section of Diabetes, Endocrinology, and Metabolism, Departments of Medicine (P.P.L., L.C.) and Molecular and Cellular Biology (L.L., A.J.M., A.L.Z., K.W.S.K., L.C.), Baylor College of Medicine, and St. Luke’s Episcopal Hospital (L.C.), Houston, Texas.

Correspondence to Lawrence Chan, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. E-mail lchan{at}bcm.tmc.edu

Objective— We investigated the molecular mechanism of nicotine-accelerated atherosclerosis in a hyperlipidemic low-density lipoprotein receptor–/– mouse model.

Methods and Results— Low-density lipoprotein receptor–/– mice received time-release nicotine or placebo pellets for 90 days. Aortic lesion size was 2.5 times larger in nicotine-treated than in placebo-treated mice (P<0.001). A mild increase in lipids was seen in treated mice. We quantified 18 different serum cytokines and found a significant increase of tumor necrosis factor {alpha}, interleukin 1ß, and keratinocyte-derived chemokine in nicotine-treated mice. Among 107 nuclear factor {kappa}B (NF-{kappa}B) target genes screened from the aorta, we found that nicotine treatment upregulated only 4 atherogenic genes including vascular adhesion molecule 1 and cyclooxygenase 2 on day 60 and platelet-derived growth factor B and platelet 12-lipoxygenase on day 90. At the cellular level, nicotine induced tumor necrosis factor {alpha} and inducible nitric oxide synthase expression in RAW264.7 cells via the nicotinic acetylcholine receptors. Induction was confirmed in peritoneal macrophages isolated from nicotine-treated mice. Finally, we showed that preconditioned medium from nicotine-treated RAW264.7 cells activated NF-{kappa}B in human smooth muscle cells and vascular endothelial cells as evidenced by nuclear localization and electromobility shift assay.

Conclusions— Chronic nicotine exposure augments atherosclerosis by enhancing the production of proinflammatory cytokines by macrophages, which, in turn, activate atherogenic NF-{kappa}B target genes in the aortic lesions.

We investigated the molecular mechanism of nicotine-accelerated atherosclerosis in the hyperlipidemic LDLR–/– mouse model. Our findings reveal a novel mechanism of nicotine-mediated atherogenesis. Nicotine directly activates macrophages via the nicotinic acetylcholine receptor, activating multiple downstream events, leading to NF-{kappa}B–mediated inflammation in the arterial wall and accelerated atherosclerosis.


Key Words: nicotine • atherosclerosis • inflammation • macrophages • NF-kB




This article has been cited by other articles:


Home page
FASEB J.Home page
S. S. Barbieri and B. B. Weksler
Tobacco smoke cooperates with interleukin-1{beta} to alter {beta}-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo
FASEB J, June 1, 2007; 21(8): 1831 - 1843.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Abbasi, H. M. F. Farin, C. Lamendola, T. McLaughlin, E. A. Schwartz, G. M. Reaven, and P. D. Reaven
The Relationship between Plasma Adiponectin Concentration and Insulin Resistance Is Altered in Smokers
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5002 - 5007.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
T. S. Pandit, L. Sikora, G. Muralidhar, S. P. Rao, and P. Sriramarao
Sustained Exposure to Nicotine Leads to Extramedullary Hematopoiesis in the Spleen
Stem Cells, November 1, 2006; 24(11): 2373 - 2381.
[Abstract] [Full Text] [PDF]